Nagashima Kazuki, Tanaka Rin, Nakahara Miyu, Omori Asuka, Watanabe Machiko, Sekine Yuko
Laboratory of Practical Pharmacy, Graduate School and Faculty of Pharmaceutical Sciences, Chiba University, Chiba, Japan.
Laboratory of Clinical Pharmaceutics, Faculty of Pharma-Science, Teikyo University, Tokyo, Japan.
Glob Health Med. 2025 Feb 28;7(1):49-56. doi: 10.35772/ghm.2024.01071.
Pharmacists who provide medication to patients immediately before they overdose should intervene appropriately; however, little information exists on the types and amounts of over-the-counter (OTC) drugs that are dangerous. This study investigated the toxicity and characteristics of overdosing on a single package of commercially available OTC drugs in humans. We researched 14,107 OTC drugs. The number of products that could contain a lethal dose if taken as a single package was 1,223 (8.7%) and a toxic dose was 2,982 (21.1%). A single product containing a lethal dose to humans by therapeutic category included skin drugs ( = 672, 25.0%), psychotropic drugs ( = 288, 17.9%), and public health drugs ( = 92, 26.1%) in descending order. Comparing before and after April 2023, the number of OTC pharmaceuticals that contained ingredients that may be abused, significantly increased: psychotropic drugs (44.9% increase), respiratory drugs (8.2% increase), and urogenital and anal organs drugs (3.5% increase) ( < 0.05). These products had not been previously designated as hazardous despite their potential for abuse. The registrants in the "Drug Database for Overdose Prevention" that made these public included 199 pharmacists, registered sellers, and doctors as of July 31, 2024. The city with the most users was Osaka (377 users) and an average engagement time of 41.8 seconds, followed by Sapporo, Fukuoka, and Nagoya. These areas were consistent with urban centers and high numbers of emergency transports due to overdose. Our findings provide important pharmaceutical information that pharmacists can use for their gatekeeper activities.
在患者过量服药前即刻为其提供药物的药剂师应进行适当干预;然而,关于危险的非处方药(OTC)的类型和数量的信息却很少。本研究调查了人类单次服用一整包市售非处方药过量的毒性和特征。我们研究了14107种非处方药。如果单次服用一整包可能含有致死剂量的产品数量为1223种(8.7%),有毒剂量的产品数量为2982种(21.1%)。按治疗类别,单次服用对人类含有致死剂量的单一产品依次为皮肤用药(=672种,25.0%)、精神药物(=288种,17.9%)和公共卫生药物(=92种,26.1%)。比较2023年4月前后,含有可能被滥用成分的非处方药品数量显著增加:精神药物(增加44.9%)、呼吸药物(增加8.2%)以及泌尿生殖和肛门器官药物(增加3.5%)(<0.05)。尽管这些产品有被滥用的可能性,但此前并未被指定为危险药品。截至2024年7月31日,在“过量预防药物数据库”中登记这些信息的有199名药剂师、注册销售商和医生。用户最多的城市是大阪(377名用户),平均参与时间为41.8秒,其次是札幌、福冈和名古屋。这些地区与城市中心以及因过量服药导致的大量紧急转运情况相符。我们的研究结果提供了重要的药学信息,药剂师可将其用于守门人活动。